Publications by authors named "Murray Barclay"

Claim this Profile
A
An update on Helicobacter pylori diagnosis in New Zealand.
Jan Kubovy, Murray Barclay

N Z Med J· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inpatient Management of Gout: Serum Urate Testing and Allopurinol Dose Adjustment.
Kate Alfeld, Murray L Barclay, Richard McNeill, Chris Frampton, Matt Doogue

J Rheumatol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A clinical decision support alert to promote timely laxative use in in-patients prescribed clozapine.
Milan Sundermann, Susanna Every-Palmer, Murray Barclay, Paul K L Chin

BJPsych Open· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Homogenous Mobility Shift Assay for Infliximab and Adalimumab Anti-drug Antibody Detection in the Clinical Laboratory.
Paula Elizabeth Keating, Barry D Hock, Paul K L Chin, John Liston O'Donnell, Murray Lindsay Barclay

Ther Drug Monit· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prevalence and clinical features of leflunomide-associated peripheral neuropathy in patients with rheumatic disease in a New Zealand cohort.
Gursimran Kaur, Murray Barclay, Joanne Mitchell, Sarah Jordan, Simon Stebbings

Int J Rheum Dis· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.
Dahham Alsoud, Dirk Jan A R Moes, Zhigang Wang, Rani Soenen, Zohra Layegh, Murray Barclay

Ther Drug Monit· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colchicine: the good, the bad, the ugly and how to minimize the risks.
Lisa K Stamp, Carl Horsley, Leanne Te Karu, Nicola Dalbeth, Murray Barclay

Rheumatology (Oxford)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship Between Adalimumab Concentrations, Antidrug Antibodies, and Disease Activity in Rheumatoid Arthritis: A Cross-Sectional Observational Study.
Lisa K Stamp, Paula Keating, Christopher Frampton, Murray L Barclay, Niamh Fanning

J Rheumatol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uphill battle: Innovation of thiopurine therapy in global inflammatory bowel disease care.
Ahmed B Bayoumy, Chris J J Mulder, Azhar R Ansari, Murray L Barclay, Tim Florin

Indian J Gastroenterol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Monitoring methotrexate polyglutamates in Crohn's disease.
Murray L Barclay, Lisa K Stamp

Aliment Pharmacol Ther· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immediate effect of caffeine on sympathetic nerve activity: why coffee is safe? A single-centre crossover study.
Jennifer M Butler, Christopher M Frampton, Grant Moore, Murray L Barclay, David L Jardine

Clin Auton Res· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Four-year review of New Zealand laboratory infliximab and adalimumab concentration results indicating potential for improved dosing.
Paula E Keating, Barry D Hock, Stewart M Smith, Paul K L Chin, John L O'Donnell, Murray L Barclay

Intern Med J· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rectally Administrated Thioguanine for Distal Ulcerative Colitis: A Multicenter Case Series.
Femke Crouwel, Melek Simsek, Amarylle S van Doorn, Chris J J Mulder, Hans J C Buiter, Murray L Barclay

Inflamm Bowel Dis· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in inpatient medicine prescribing during COVID-19 lockdown.
Millie Y Wang, Murray L Barclay, Paul K L Chin, Matthew P Doogue

Intern Med J· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Timing of Live Attenuated Vaccination in Infants Exposed to Infliximab or Adalimumab in Utero: A Prospective Cohort Study in 107 Children.
Zheng Liu, Mette Julsgaard, Xiao Zhu, Jennifer Martin, Murray L Barclay

J Crohns Colitis· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Helicobacter pylori in New Zealand: current diagnostic trends and related costs.
Jan Kubovy, Murray L Barclay

N Z Med J· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omeprazole Treatment Failure in Gastroesophageal Reflux Disease and Genetic Variation at the Locus.
Ping Siu Kee, Simran D S Maggo, Martin A Kennedy, Murray L Barclay, Allison L Miller

Front Genet· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maternal thiopurine metabolism during pregnancy in inflammatory bowel disease and clearance of thiopurine metabolites and outcomes in exposed neonates.
Emma Flanagan, Emily K Wright, Winita Hardikar, Miles P Sparrow, William R Connell, Murray Barclay

Aliment Pharmacol Ther· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A nationwide survey on therapeutic drug monitoring of anti-tumour necrosis factor agents for inflammatory bowel disease.
Pepijn W A Thomas, Paul K L Chin, Murray L Barclay

Intern Med J· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of therapeutic drug monitoring in inflammatory bowel disease.
Richard P McNeill, Murray L Barclay

Curr Opin Pharmacol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 1 g dose of intravenous iron is sufficient to treat iron deficiency anaemia.
Syarihan Karim, Jennifer M Butler, Murray L Barclay

Intern Med J· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical decision support in a hospital electronic prescribing system informed by local data: experience at a tertiary New Zealand centre.
Paul K L Chin, QianYi Chuah, Amanda M Crawford, Olivia R Clendon, Philip G Drennan, Murray L Barclay

Intern Med J· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic review with meta-analysis: SARS-CoV-2 stool testing and the potential for faecal-oral transmission.
Amarylle S van Doorn, Berrie Meijer, Chris M A Frampton, Murray L Barclay, Nanne K H de Boer

Aliment Pharmacol Ther· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Noninferiority Randomized Clinical Trial of the Use of the Smartphone-Based Health Applications IBDsmart and IBDoc in the Care of Inflammatory Bowel Disease Patients.
Andrew McCombie, Russell Walmsley, Murray Barclay, Christine Ho, Tobias Langlotz

Inflamm Bowel Dis· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationships Between Allopurinol Dose, Oxypurinol Concentration and Urate-Lowering Response-In Search of a Minimum Effective Oxypurinol Concentration.
Lisa K Stamp, Peter T Chapman, Murray Barclay, Anne Horne, Christopher Frampton

Clin Transl Sci· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis